Tag Archives: afatinib
Afatinib (Gilotrif) Efficacious in the EGFR+ NSCLC With Uncommon Mutations, Regardless of Ethnicity
According to outcomes from a pooled analysis cane during the 2020 IASLC North America Conference on Lung Cancer, afatinib was […]
